RA CAPITAL MANAGEMENT, L.P. - 04 Jun 2025 SCHEDULE 13D/A Report for TYRA BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (TYRA)

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 22% ownership in TYRA BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (TYRA) on 04 Jun 2025."

Quick Takeaways

RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A for TYRA BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (TYRA).
Disclosed ownership: 22%.
Date of event: 04 Jun 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title	CIK
RA Capital Management, L.P.	22%	11,899,788	11,899,788	/s/ Peter Kolchinsky	By Peter Kolchinsky, Authorized Signatory	0001346824
Peter Kolchinsky	22%	11,899,788	11,899,788	/s/ Peter Kolchinsky	Peter Kolchinsky	0001384859
Rajeev Shah	22%	11,899,788	11,899,788	/s/ Rajeev Shah	Rajeev Shah	0001619841
RA Capital Healthcare Fund, L.P.	19%	9,909,154	9,909,154	/s/ Peter Kolchinsky	By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager	0001315082